Please login to the form below

Not currently logged in

Young diabetes patients in England and Wales receive fewer vital checks

Less than a third with type 1 diabetes receive eight of nine recommended care processes


Diabetes patients under 40 in England and Wales receive fewer vital checks and hit treatment targets less often than older age groups.

The National Diabetes Audit for 2012-2013 found that, of approximately 130,000 patients under the age of 40, only 29.1% with type 1 diabetes and 46.3% with type 2 diabetes received at least eight of the nine NICE recommended care processes.

These annual checks assess the effectiveness of diabetes treatment, as well as cardiovascular risk factors such as blood pressure, serum cholesterol, body mass index and smoking and the emergence of early complications including eye screening, and kidney and foot surveillance.

Patients aged 65 to 79 were found to have the highest percentage of receiving eight care processes, with 59.9% for those with type 1 diabetes and 66.7% with type 2.

Dr Bob Young, clinical lead for the audit, said: “This year's report has shown that there is age inequality for the care and treatment received by patients with diabetes.

“Younger people are receiving substantially worse routine care and treatment than older patients and yet will live longer with their diabetes. They are therefore most at risk of developing complications that will affect their health and could lead to mortality.”

The audit, which collected data on the care of over two million people in England and Wales with diabetes, also measured the prevalence of three NICE recommended treatment targets that should be monitored and met for diabetes patients - glucose control, blood pressure and serum cholesterol.

For people aged under 40, 14.7% of patients with type 1 diabetes and 24.3% with type 2 met all three treatment targets. Patients aged 80 and over have the highest treatment target achievement rate with 25.5% with type 1 and 45.1% with type 2 meeting all three treatment targets.

The audit is the largest of its kind in the world and is managed by the Health and Social Care Information Centre in partnership with Diabetes UK.

Article by
Kirstie Pickering

3rd October 2014

From: Healthcare



Featured jobs

Subscribe to our email news alerts


Add my company

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...